Global Tissue Testing By Product Type (Instruments and Consumables), Technology (Haematoxylin and Eosin (H&E), Immunohistochemistry (IHC), In Situ Hybridization, Primary and Special Staining, Digital Pathology and Workflow and Anatomic Pathology), Disease (Non-Small Cell Lung Cancer, Breast Cancer, Lymphoma, Gastric Cancer, Prostate Cancer and Others), End User (Hospitals, Contract Research Organizations (CROs), Ambulatory Surgical Centres, Diagnostic Laboratories, Research Organizations, and Biotechnology Companies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Tissue Testing Market
Data Bridge Market Research analyses that the tissue testing market will exhibit a CAGR of around 5.83% for the forecast period of 2021-2028. Rising awareness among the populations in regards to maintaining good health, increased focus by diagnostic laboratories on the adoption of advanced technologies and to present a more efficient approach in their operations and rising expenditure on the healthcare infrastructure development especially in the developing economies are the major factors attributable to the growth of tissue testing market.
From the name itself, it is clear that tissue testing is the testing of specific tissues by capturing the biological context of diseases. Tissue testing healthcare technology is used to diagnose a wide range of diseases. It is regarded as one of the advanced diagnostic technology.
Upsurge in the prevalence of cancer among the population is one of the major factors fostering the growth of market. Rising advent of various innovations and researches in the field of healthcare to develop diagnostic technologies and tissue diagnostics is another market growth determinant. Ever-rising geriatric population which is most susceptible to chronic diseases, surge in the lifestyle diseases, and increasing personal disposable income will further generate lucrative market growth opportunities.
However, high costs associated with tissue testing healthcare technology will act as a market growth restraint. Non-favourable reimbursement scenarios in developing and under developed economies will further derail the market growth rate. Lack of awareness in such economies will further pose challenges for the market.
This tissue testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on tissue testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Tissue Testing Market Scope and Market Size
The tissue testing market is segmented on the basis of product type, technology, disease, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on product type, the global tissue testing market has been divided into instrument and consumables. Instruments segment is sub-segmented into slide-staining systems, scanners, tissue-processing systems and others. Consumables segment is sub-segmented into antibodies, reagents, kits and probes.
- Based on the technology, the tissue testing market is segmented into haematoxylin and eosin (H&E), immunohistochemistry (IHC), in situ hybridization, primary and special staining, digital pathology and workflow and anatomic pathology. Immunohistochemistry (IHC) segment is sub-segmented into instruments and consumables. Instruments segment is further bifurcated into slide-staining systems, scanners, tissue-processing systems, and others. Consumables segment is further bifurcated into antibodies, reagents, kits, and probes. In situ hybridization segment is sub-segmented into instruments, consumables and software. Digital pathology and workflow segment is sub-segmented into whole slide imaging, image analysis informatics, and information management system storage and communication. Anatomic pathology segment is sub-segmented into instruments and consumables. Instruments segment is further bifurcated into microtomes and cryostat microtomes, tissue processors, automatic strainers and others. Consumables segment is further bifurcated into antibodies, reagents, kits and probes.
- Based on the disease, the tissue testing market is segmented into non-small cell lung cancer, breast cancer, lymphoma, gastric cancer, prostate cancer and others.
- Based on the end user, the tissue testing market is segmented into hospitals, contract research organizations (CROs), ambulatory surgical centres, diagnostic laboratories, research organizations and biotechnology companies.
Tissue Testing Market Country Level Analysis
The tissue testing market is analysed, and market size insights and trends are provided by country, product type, technology, disease, and end user as referenced above.
The countries covered in the tissue testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the tissue testing market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the prevailing sophisticated level of healthcare facilities, increasing expenditure for research and development activities, and surge in the cases of cancer. Asia-Pacific, on the other hand, is projected to exhibit the highest growth rate during the forecast period owing to the large patient pool, increased expenditure on healthcare infrastructure, and increasing personal disposable income. Rising prevalence of chronic diseases is also driving the market growth in this region.
The country section of the tissue testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The tissue testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tissue testing market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Tissue Testing Market Share Analysis
The tissue testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to tissue testing market.
The major players covered in the tissue testing market report are Abbott, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Merck KGaA, Thermo Fisher Scientific Inc., Bio SB, Danaher., bioMérieux SA, QIAGEN, BD, GENERAL ELECTRIC COMPANY, Cell Signaling Technology, Inc., Genomic Health, Inc., BioGenex., Siemens Healthcare GmbH, Sakura Finetek Japan Co.,Ltd., Abcam plc., Konica Minolta, Inc., Tissue Solutions Ltd., and 3DHISTECH Ltd. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-